title: Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma.
abstract: BACKGROUND
  Prior work showed that whole blood, plasma, and serum injections are damaging to the neonatal rodent brain in a model of intracerebral/periventricular hemorrhage. Thrombin alone is also damaging. In adult animal models of hemorrhagic stroke, the protease-activated (thrombin) receptor PAR1 mediates some of the brain damage. We hypothesized that PAR1 interference will reduce the adverse effects of blood products on immature rodent brain and cells.
  
  
  RESULTS
  Cultured oligodendrocyte precursor cells from rats and mice were exposed to blood plasma with and without the PAR1 antagonists SCH-79797 or BMS-200261. In concentrations previously shown to have activity on brain cells, neither drug showed evidence of protection against the toxicity of blood plasma. Newborn mice (wild type, heterozygous, and PAR1 knockout) were subjected to intracerebral injection of autologous whole blood into the periventricular region of the frontal lobe. Cell proliferation, measured by Ki67 immunoreactivity in the subventricular zone, was suppressed at 1 and 2 days, and was not normalized in the knockout mice. Cell apoptosis, measured by activated caspase 3 immunoreactivity, was not apparent in the subventricular zone. Increased apoptosis in periventricular striatal cells was not normalized in the knockout mice.
  
  
  CONCLUSIONS
  Interference with the thrombin-PAR1 system does not reduce the adverse effects of blood on germinal cells of the immature rodent brain. PAR1 interference is unlikely to be a useful treatment for reducing the brain damage that accompanies periventricular (germinal matrix) hemorrhage, a common complication of premature birth.
authors: Department of Pathology, University of Manitoba, and Children's Hospital Research Institute of Manitoba, 401 Brodie Centre, 715 McDermot Avenue, Winnipeg, MB, R3E 3P5, Canada. XMao@mich.ca.
authors: Xiaoyan
authors: X
authors: Mao
authors: Department of Pathology, University of Manitoba, and Children's Hospital Research Institute of Manitoba, 401 Brodie Centre, 715 McDermot Avenue, Winnipeg, MB, R3E 3P5, Canada. marc.delbigio@umanitoba.ca.
authors: Marc R
authors: MR
authors: Del Bigio
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001769:Blood; D001921:Brain / Q000254:growth & development / Q000378:metabolism / Q000473:pathology; D002478:Cells, Cultured; D007276:Injections, Intraventricular; D020547:Lateral Ventricles / Q000254:growth & development / Q000378:metabolism* / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010949:Plasma; D051381:Rats; D017207:Rats, Sprague-Dawley; D044463:Receptor, PAR-1 / Q000172:deficiency*
chemical_list: D044463:Receptor, PAR-1
references: Arch Biochem Biophys. 1985 Mar;237(2):520-34
references: 3919650
references: J Neurochem. 2009 Jun;109(5):1285-99
references: 19476544
references: J Biol Chem. 2008 Jul 18;283(29):20600-11
references: 18474593
references: J Neuropathol Exp Neurol. 2003 Nov;62(11):1154-65
references: 14656073
references: Thromb Haemost. 2011 Dec;106(6):1020-33
references: 21979864
references: Brain Res. 2009 Dec 11;1305:1-13
references: 19765562
references: Pediatr Res. 2010 Jan;67(1):1-8
references: 19816235
references: J Anat. 1980 Mar;130(Pt 2):391-415
references: 7400043
references: Rejuvenation Res. 2010 Feb;13(1):27-37
references: 20230276
references: Basic Clin Pharmacol Toxicol. 2007 Jul;101(1):63-9
references: 17577318
references: J Biol Chem. 2003 Aug 15;278(33):31177-83
references: 12775717
references: J Neurochem. 2009 Nov;111(3):828-36
references: 19719823
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13019-24
references: 14559973
references: PLoS One. 2011;6(6):e20894
references: 21698109
references: Dev Cell. 2010 Jan 19;18(1):25-38
references: 20152175
references: Cereb Cortex. 2003 Jun;13(6):580-7
references: 12764031
references: J Neurochem. 2002 Feb;80(4):655-66
references: 11841573
references: Proteomics. 2005 Aug;5(13):3414-22
references: 16038021
references: J Neurochem. 2013 Oct;127(2):283-98
references: 23647384
references: Methods. 1998 Nov;16(3):282-92
references: 10071067
references: Neuroscience. 2001;105(1):7-17
references: 11483296
references: Neurosurg Focus. 2012 Apr;32(4):E8
references: 22463118
references: Eur J Neurosci. 1998 May;10(5):1590-607
references: 9751132
references: Transl Stroke Res. 2014 Aug;5(4):472-5
references: 24323711
references: J Vet Sci. 2010 Jun;11(2):121-4
references: 20458152
references: Stroke. 2012 Sep;43(9):2476-82
references: 22811450
references: Exp Neurol. 2009 May;217(1):136-46
references: 19416668
references: J Neurochem. 2006 Nov;99(3):759-69
references: 16903872
references: Neuron. 2004 Feb 19;41(4):563-72
references: 14980205
references: Brain Pathol. 2005 Jul;15(3):241-9
references: 16196391
references: Neuroscience. 2004;126(1):69-82
references: 15145074
references: Science. 2001 Aug 31;293(5535):1666-70
references: 11533492
references: Nature. 2000 Sep 14;407(6801):258-64
references: 11001069
references: J Neurosci. 2005 Aug 10;25(32):7289-98
references: 16093378
references: Nat Neurosci. 2010 Jun;13(6):767-75
references: 20436479
references: Glia. 2013 Sep;61(9):1456-70
references: 23832758
references: Nat Neurosci. 2004 May;7(5):483
references: 15114362
references: Neurobiol Dis. 2013 Feb;50:13-20
references: 23000356
references: Brain Pathol. 2005 Oct;15(4):273-80
references: 16389939
references: Brain. 2011 May;134(Pt 5):1344-61
references: 21478186
references: J Anat. 2007 Aug;211(2):164-76
references: 17634059
references: J Neurosci. 2005 Apr 27;25(17):4319-29
references: 15858058
references: Nat Rev Neurosci. 2007 Jun;8(6):438-50
references: 17514197